MAGI2 and breast cancer: In the breast cancer MDA-MB-231 and MCF7 cell lines, down-regulation of miR-487a restores MAGI2 expression, suppresses epithelial–mesenchymal transition (EMT), and inhibits the invasive phenotype [139].